We prospectively designed the workflow to get participants with positive IgM, which related to acute infection of SARS-CoV-2, subsequently tested with a nasopharyngeal swab for PCR which was the gold standard for diagnosis COVID-19 during the study period. This evidence concerns the gene CD40LG and COVID-19.